Few other techniques in the laboratory so exquisitely blend the scientific fields of analytical chemistry, physics, and biology better than mass spectrometry (MS). Put...
RealSeq-DC builds on existing technology to allow researchers the ability to analyze and log short, single-stranded DNA fragments.
Sequenom agreed to a clinical research collaboration with the University of California, San Diego Moores Cancer Center. Moores will explore the utility of Sequenom's...
The amount of the protein, NR2F1, present indicates whether a breast cancer patient will likely relapse and develop deadly bone metastases
Natera will test the efficacy of its cell-free DNA liquid biopsy test to monitor tumor burden, treatment response and residual disease.
ImmunoXpert has the potential to significantly reduce overprescribing antibiotics by quickly differentiating bacterial and viral infections
Scientists develop method for minimizing DNA errors acquired when processing samples, generating extremely sensitive liquid biopsy technique
Company also plans to enhance its proprietary No Cell Left Behind technology to include characterization of rare leukocyte cell populations.
A study of mixed martial arts fighters discovered two biomarker signatures in the saliva and blood that diagnoses TBI with 90% accuracy
Collaboration to combine Predicine’s GeneRADAR molecular insights platform with Flagship’s AI-enabled cTA digital pathology platform.